Jessica R Barrett1, Derek K Tracy, Giovanni Giaroli. 1. 1 Cognition, Schizophrenia, & Imaging Laboratory, Department of Psychosis Studies, the Institute of Psychiatry , King's College, London, United Kingdom .
Abstract
OBJECTIVE: This systematic review assessed current evidence on sleep medication for attention-deficit/hyperactivity disorder (ADHD) patients, to establish appropriate guidance for clinicians faced with prescribing such medications. METHODS: Five articles (based on four pharmacological compounds) out of a total 337 were identified as evidence to guide pharmacological treatment of ADHD-related sleep disorders. Data regarding participant characteristics, measures of ADHD diagnosis, measures of sleep, and outcome data were extracted. RESULTS: Zolpidem and L-theanine both displayed a poor response in reducing sleep latency and increasing total sleep time, however L-theanine did produce an increase in sleep efficiency. Zolpidem produced high levels of side effects, leading to the largest dropout rate of all five studies. Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency. CONCLUSIONS: There is a relative paucity of evidence for the pharmacological treatment of ADHD-related sleep disorders; therefore, further research should be conducted to replicate these findings and obtain reliable results.
OBJECTIVE: This systematic review assessed current evidence on sleep medication for attention-deficit/hyperactivity disorder (ADHD) patients, to establish appropriate guidance for clinicians faced with prescribing such medications. METHODS: Five articles (based on four pharmacological compounds) out of a total 337 were identified as evidence to guide pharmacological treatment of ADHD-related sleep disorders. Data regarding participant characteristics, measures of ADHD diagnosis, measures of sleep, and outcome data were extracted. RESULTS:Zolpidem and L-theanine both displayed a poor response in reducing sleep latency and increasing total sleep time, however L-theanine did produce an increase in sleep efficiency. Zolpidem produced high levels of side effects, leading to the largest dropout rate of all five studies. Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency. CONCLUSIONS: There is a relative paucity of evidence for the pharmacological treatment of ADHD-related sleep disorders; therefore, further research should be conducted to replicate these findings and obtain reliable results.
Authors: Sandra J England; Daniel L Picchietti; Barbara Vera Couvadelli; Barbara C Fisher; Fouzia Siddiqui; Mary L Wagner; Wayne A Hening; Daniel Lewin; Glenna Winnie; Barry Cohen; Arthur S Walters Journal: Sleep Med Date: 2011-04-03 Impact factor: 3.492
Authors: Samuele Cortese; Stephen V Faraone; Eric Konofal; Michel Lecendreux Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-09 Impact factor: 8.829
Authors: Jeffrey L Blumer; Robert L Findling; Weichung Joe Shih; Christina Soubrane; Michael D Reed Journal: Pediatrics Date: 2009-05 Impact factor: 7.124
Authors: Shweta Anand; Henry Tong; Frank M C Besag; Esther W Chan; Samuele Cortese; Ian C K Wong Journal: Paediatr Drugs Date: 2017-06 Impact factor: 3.022